CSF1R and glioblastoma: One of the first studies to show that TAM re‐education within TME exerts an effect on tumor regression was reported in 2013, using a colony‐stimulating factor 1 receptor (CSF‐1R) inhibitor—called BLZ945—in multiple preclinical glioblastoma models.68